Bopindolol
![]() | |
Systematic (IUPAC) name | |
---|---|
(RS)-1-(tert-butylamino)-3-[(2-methyl-1H-indol-4-yl)oxy]propan-2-yl benzoate | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status |
|
Routes of administration | Oral |
Identifiers | |
CAS Number |
69010-88-4 ![]() |
ATC code | C07AA17 |
PubChem | CID 44112 |
DrugBank |
DB08807 ![]() |
ChemSpider |
40146 ![]() |
UNII |
KT304VZO57 ![]() |
KEGG |
D07537 ![]() |
ChEMBL |
CHEMBL357995 ![]() |
Chemical data | |
Formula | C23H28N2O3 |
Molar mass | 380.48 g/mol |
| |
| |
![]() ![]() |
Bopindolol (INN) is a beta blocker. It is an ester which acts as a prodrug for pindolol.[1]
References
- ↑ Nagatomo T, Hosohata Y, Ohnuki T, Nakamura T, Hattori K, Suzuki J, Ishiguro M. (Spring 2001). "Bopindolol: pharmacological basis and clinical implications". Cardiovasc Drug Rev. 19 (1): 9–24. doi:10.1111/j.1527-3466.2001.tb00180.x. PMID 11314603.
|
This article is issued from Wikipedia - version of the Friday, September 04, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.